IMMUNE CHECKPOINT INHIBITORS
Cardiotoxicity From Immune Checkpoint Inhibitors
This review focuses on current knowledge about cardiac immune checkpoint inhibitor (ICI)–related toxicity. The authors summarize the most common forms of cardiotoxicity with delineation of incidence, presentation, and treatment, as well as current knowledge gaps in ICI-associated cardiotoxicity.
IJC Heart and VasculatureMeet the Faculty
Videos
-
Immune Checkpoint Inhibitors Managing Cardiotoxicity Associated With Immune Checkpoint Inhibitor Therapy
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: Incidence and Patient Risk Factors
-
Immune Checkpoint Inhibitors Immune Checkpoint Inhibitors and Cardiotoxicity: The Pharmacist Perspective
